LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
19 hedge funds and large institutions have $6.77M invested in LAVA Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 20 → 19 (-1)
46% less capital invested
Capital invested by funds: $12.5M → $6.77M (-$5.76M)
Holders
19
Holding in Top 10
–
Calls
$174K
Puts
$66K
Top Buyers
| 1 | +$175K | |
| 2 | +$121K | |
| 3 | +$81.3K | |
| 4 |
Two Sigma Investments
New York
|
+$80.3K |
| 5 |
Two Sigma Advisers
New York
|
+$39.6K |
Top Sellers
| 1 | -$341K | |
| 2 | -$60.9K | |
| 3 | -$54.1K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$43K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$39.6K |